1. Home
  2. JWEL vs PULM Comparison

JWEL vs PULM Comparison

Compare JWEL & PULM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Jowell Global Ltd.

JWEL

Jowell Global Ltd.

HOLD

Current Price

$2.16

Market Cap

5.7M

ML Signal

HOLD

Logo Pulmatrix Inc.

PULM

Pulmatrix Inc.

HOLD

Current Price

$1.46

Market Cap

5.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JWEL
PULM
Founded
2012
2003
Country
China
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.7M
5.2M
IPO Year
2020
2013

Fundamental Metrics

Financial Performance
Metric
JWEL
PULM
Price
$2.16
$1.46
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
10.1K
★ 18.6K
Earning Date
04-30-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 46.18
EPS
★ N/A
N/A
Revenue
N/A
★ $7,910,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$67.27
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 5069.93
52 Week Low
$1.47
$1.16
52 Week High
$5.17
$4.98

Technical Indicators

Market Signals
Indicator
JWEL
PULM
Relative Strength Index (RSI) 43.32 50.46
Support Level $2.05 $1.41
Resistance Level $2.41 $1.82
Average True Range (ATR) 0.21 0.11
MACD -0.02 0.00
Stochastic Oscillator 28.22 51.09

Price Performance

Historical Comparison
JWEL
PULM

About JWEL Jowell Global Ltd.

Jowell Global Ltd is a cosmetics, health, nutritional supplements, and household products e-commerce platform in China. The company offers its branded products to customers and also sells and distributes products from other companies on its platform. In addition, it allows third parties to open their stores on its platform for a service fee based on their sales revenues generated from their online stores and provides them with information about market needs, enabling them to manage their sales effort, as well as an effective platform to promote their brands. The company currently operates under four sales channels: Online Direct Sales, Authorized Retail Store Distribution, Third-party Merchants, and Live streaming marketing.

About PULM Pulmatrix Inc.

Pulmatrix Inc is a biopharmaceutical company focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).

Share on Social Networks: